| |
|
|
| • |
Patients at Qualified Dialysis Centers (QDCs) showed better clinical profiles, including higher dialysis adequacy (Kt/V) and hemoglobin, and lower serum phosphorus than non-QDC patients. |
| • |
After adjusting for multiple confounders, QDC treatment independently improved survival, reducing all-cause mortality risk by 10% (HR, 0.90; p < 0.001). |
| • |
This survival benefit was most prominent in younger patients (<65 years) and those with shorter dialysis vintages, though not significant for elderly or Medicaid patients. |
|
| |
|
|
| • |
High-risk husband-to-wife (H2W) recipients experienced a significantly higher 1-year acute antibody-mediated rejection rate compared to wife-to-husband (W2H) recipients (20.4% vs. 3.1%). |
| • |
Long-term patient and allograft survival, kidney function, and infection rates showed no significant differences regardless of donor direction. |
| • |
Although long-term outcomes are similar regardless of donor direction, high-risk H2W recipients face a greater risk of early rejection and require careful clinical monitoring and management. |
|
 |
|
